Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Learn CW Investment SPAC | LCW | May 31, 2024 | 10.89 | +0.09 |
LeddarTech | LDTC | May 31, 2024 | 2.16 | -0.46 |
Lee Enterprises | LEE | May 31, 2024 | 12.70 | -1.09 |
Legacy Housing | LEGH | May 31, 2024 | 23.23 | +0.22 |
LegalZoom.com | LZ | May 31, 2024 | 8.78 | +0.92 |
Legato Merger III | LEGT | May 31, 2024 | 10.10 | 0.00 |
Legend Biotech ADR | LEGN | May 31, 2024 | 40.01 | -7.66 |
Legg Mason Low Volatility High Dividend ETF | LVHD | May 31, 2024 | 36.22 | +2.00 |
Leggett & Platt | LEG | May 31, 2024 | 11.60 | +5.26 |
Leidos | LDOS | May 31, 2024 | 147.05 | +1.22 |
LeMaitre Vascular | LMAT | May 31, 2024 | 78.88 | +0.14 |
Lemonade | LMND | May 31, 2024 | 16.51 | -0.24 |
LendingClub | LC | May 31, 2024 | 8.92 | +0.79 |
LendingTree | TREE | May 31, 2024 | 42.99 | -3.39 |
Lendway | LDWY | May 31, 2024 | 5.41 | +0.84 |
Lennar A | LEN | May 31, 2024 | 160.35 | +2.11 |
Lennar B | LEN-B | May 31, 2024 | 146.26 | +0.88 |
Lennox International | LII | May 31, 2024 | 502.60 | +1.73 |
LENSAR | LNSR | May 31, 2024 | 4.70 | +8.29 |
LENZ Therapeutics | LENZ | May 31, 2024 | 15.29 | 0.00 |
Leonardo DRS | DRS | May 31, 2024 | 23.55 | +0.68 |
Lesaka Technologies | LSAK | May 31, 2024 | 4.46 | -5.51 |
Leslies | LESL | May 31, 2024 | 5.72 | +0.88 |
Levi Strauss & Co A | LEVI | May 31, 2024 | 24.01 | +2.21 |
Lexaria Bioscience | LEXX | May 31, 2024 | 3.89 | -2.51 |
Lexeo Therapeutics | LXEO | May 31, 2024 | 16.63 | +3.61 |
Lexicon Pharmaceuticals | LXRX | May 31, 2024 | 1.70 | 0.00 |
LexinFintech ADR | LX | May 31, 2024 | 1.84 | -1.08 |
LG Display ADR | LPL | May 31, 2024 | 3.51 | -3.31 |
LGI Homes | LGIH | May 31, 2024 | 96.00 | +0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.